134 related articles for article (PubMed ID: 31100216)
1. Downregulation of aspartoacylase during the progression of myelin breakdown in the dmy mutant rat with mitochondrial magnesium channel MRS2 defect.
Kuwamura M; Tanimura S; Hasegawa Y; Hoshiai R; Moriyama Y; Tanaka M; Takenaka S; Nagayoshi H; Izawa T; Yamate J; Kuramoto T; Serikawa T
Brain Res; 2019 Sep; 1718():169-175. PubMed ID: 31100216
[TBL] [Abstract][Full Text] [Related]
2. Oligodendroglial pathology in the development of myelin breakdown in the dmy mutant rat.
Kuwamura M; Inumaki K; Tanaka M; Shirai M; Izawa T; Yamate J; Franklin RJ; Kuramoto T; Serikawa T
Brain Res; 2011 May; 1389():161-8. PubMed ID: 21396920
[TBL] [Abstract][Full Text] [Related]
3. A mutation in the gene encoding mitochondrial Mg²+ channel MRS2 results in demyelination in the rat.
Kuramoto T; Kuwamura M; Tokuda S; Izawa T; Nakane Y; Kitada K; Akao M; Guénet JL; Serikawa T
PLoS Genet; 2011 Jan; 7(1):e1001262. PubMed ID: 21253565
[TBL] [Abstract][Full Text] [Related]
4. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.
Traka M; Wollmann RL; Cerda SR; Dugas J; Barres BA; Popko B
J Neurosci; 2008 Nov; 28(45):11537-49. PubMed ID: 18987190
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of aspartoacylase in the rat central nervous system.
Madhavarao CN; Moffett JR; Moore RA; Viola RE; Namboodiri MA; Jacobowitz DM
J Comp Neurol; 2004 May; 472(3):318-29. PubMed ID: 15065127
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Expression of Trib3 during the Development of Myelin Breakdown in dmy Myelin Mutant Rats.
Shimotsuma Y; Tanaka M; Izawa T; Yamate J; Kuwamura M
PLoS One; 2016; 11(12):e0168250. PubMed ID: 27977799
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and morphometrical studies on myelin breakdown in the demyelination (dmy) mutant rat.
Kuwamura M; Kanehara T; Tokuda S; Kumagai D; Yamate J; Kotani T; Nakane Y; Kuramoto T; Serikawa T
Brain Res; 2004 Oct; 1022(1-2):110-6. PubMed ID: 15353220
[TBL] [Abstract][Full Text] [Related]
8. Extensive aspartoacylase expression in the rat central nervous system.
Moffett JR; Arun P; Ariyannur PS; Garbern JY; Jacobowitz DM; Namboodiri AM
Glia; 2011 Oct; 59(10):1414-34. PubMed ID: 21598311
[TBL] [Abstract][Full Text] [Related]
9. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ
Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
[TBL] [Abstract][Full Text] [Related]
10. Renewal of oligodendrocyte lineage reverses dysmyelination and CNS neurodegeneration through corrected N-acetylaspartate metabolism.
Lotun A; Li D; Xu H; Su Q; Tuncer S; Sanmiguel J; Mooney M; Baer CE; Ulbrich R; Eyles SJ; Strittmatter L; Hayward LJ; Gessler DJ; Gao G
Prog Neurobiol; 2023 Jul; 226():102460. PubMed ID: 37149081
[TBL] [Abstract][Full Text] [Related]
11. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase.
Chakraborty G; Mekala P; Yahya D; Wu G; Ledeen RW
J Neurochem; 2001 Aug; 78(4):736-45. PubMed ID: 11520894
[TBL] [Abstract][Full Text] [Related]
12. Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat.
Izawa T; Yamate J; Franklin RJ; Kuwamura M
Brain Res; 2010 Aug; 1349():105-14. PubMed ID: 20599839
[TBL] [Abstract][Full Text] [Related]
13. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time.
Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M
J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242
[TBL] [Abstract][Full Text] [Related]
14. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P
Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881
[TBL] [Abstract][Full Text] [Related]
15. Canavan disease: a white matter disorder.
Kumar S; Mattan NS; de Vellis J
Ment Retard Dev Disabil Res Rev; 2006; 12(2):157-65. PubMed ID: 16807907
[TBL] [Abstract][Full Text] [Related]
16. Abnormal myelinogenesis both in the white and gray matter of the attractin-deficient mv rat.
Izawa T; Yamate J; Franklin RJ; Kuwamura M
Brain Res; 2010 Feb; 1312():145-55. PubMed ID: 19931230
[TBL] [Abstract][Full Text] [Related]
17. Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination.
Kirmani BF; Jacobowitz DM; Namboodiri MA
Brain Res Dev Brain Res; 2003 Jan; 140(1):105-15. PubMed ID: 12524181
[TBL] [Abstract][Full Text] [Related]
18. Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat.
Wang J; Leone P; Wu G; Francis JS; Li H; Jain MR; Serikawa T; Ledeen RW
Neurochem Res; 2009 Jan; 34(1):138-48. PubMed ID: 18478328
[TBL] [Abstract][Full Text] [Related]
19. The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
Singhal NK; Huang H; Li S; Clements R; Gadd J; Daniels A; Kooijman EE; Bannerman P; Burns T; Guo F; Pleasure D; Freeman E; Shriver L; McDonough J
Exp Brain Res; 2017 Jan; 235(1):279-292. PubMed ID: 27709268
[TBL] [Abstract][Full Text] [Related]
20. Involvement of NMDA receptors in tremor expression in Aspa/Hcn1 double-knockout rats.
Nishitani A; Nagayoshi H; Takenaka S; Asano M; Shimizu S; Ohno Y; Kuramoto T
Exp Anim; 2020 Nov; 69(4):388-394. PubMed ID: 32507787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
